Global Hemostats Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- SKU ID : GIR-GIR1901230543 13658608
- |
- Publishing Date: 21-Feb-2019
- |
- Region: Global
- |
- No. of pages: 136
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Scope of the Report:
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Major manufacturers in the market are Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard and The Medicines Company.
To grab more market, the little companies have to expand the technology, capital investment and brand influence. To meet the challenge of the little companies and keep their leading stage, leading companies need to increase the technology innovation and speed up the product upgrading. In the future, Hemostats market will be a market of fierce competition.
In order to feed the changing technical requirements, Hemostats manufacturers need to pay attention to the technical innovation. In future, Thrombin-Based Hemostats will be the technology trends of Hemostats.
The worldwide market for Hemostats is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 3070 million US$ in 2024, from 2160 million US$ in 2019, according to a new study.
This report focuses on the Hemostats in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Market Segment by Applications, can be divided into
Prehospital Treatment
Hospital Treatment
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemostats product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemostats, with price, sales, revenue and global market share of Hemostats in 2017 and 2018.
Chapter 3, the Hemostats competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemostats breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Hemostats market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Hemostats sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
Major manufacturers in the market are Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard and The Medicines Company.
To grab more market, the little companies have to expand the technology, capital investment and brand influence. To meet the challenge of the little companies and keep their leading stage, leading companies need to increase the technology innovation and speed up the product upgrading. In the future, Hemostats market will be a market of fierce competition.
In order to feed the changing technical requirements, Hemostats manufacturers need to pay attention to the technical innovation. In future, Thrombin-Based Hemostats will be the technology trends of Hemostats.
The worldwide market for Hemostats is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 3070 million US$ in 2024, from 2160 million US$ in 2019, according to a new study.
This report focuses on the Hemostats in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Market Segment by Applications, can be divided into
Prehospital Treatment
Hospital Treatment
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemostats product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemostats, with price, sales, revenue and global market share of Hemostats in 2017 and 2018.
Chapter 3, the Hemostats competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemostats breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Hemostats market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Hemostats sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
